REGULAR use of aspirin or other nonsteroidal anti-inflammatory drugs was found to be associated with a lower risk of early-onset colorectal cancer.
"What we have here is a 15% reduction for all adenomas and 33% for those with advanced histology, which to us is quite substantial," said the lead researcher Dr Cassandra Fritz.
Learn more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jul 23
